I take it to mean he won't be satisfied with a 10 to 20 % revenue split on a drug, especially until he knows the true extent of the viable indications. Remember the Jackpot comment? Does it work for acne? HS? UP?

Prurisol should be easier to value. That data will be available very soon. If they decide to partner Prurisol would be my bet.